New eye drops could offer Needle-Free hope for diabetic vision loss
NCT ID NCT06599684
First seen Jan 30, 2026 · Last updated Apr 24, 2026 · Updated 10 times
Summary
This study tested an eye drop called INV-102 in 19 adults with diabetic macular edema (DME), a condition that causes vision loss in people with diabetes. The goal was to see if the drops can reduce swelling and improve eye health over 8 to 12 weeks. If successful, this could provide a simpler, non-invasive treatment option compared to current injections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MedTrials, Inc.
Dallas, Texas, 75204, United States
Conditions
Explore the condition pages connected to this study.